Crescent Capital president buys 4,500 shares
Crescent Capital BDC, Inc. president and director Henry Chung reported an open‑market purchase of 4,500 shares of common stock at $11.45 per share on May 21, 2026.
Rhea-AI Filing Summary
Crescent Capital BDC, Inc. president and director Henry Chung reported an open‑market purchase of 4,500 shares of common stock at $11.45 per share on May 21, 2026. Following this transaction, he directly holds 20,722 shares, including 945 shares acquired through dividend reinvestment in 2026.
Positive
- None.
Negative
- None.
Insights
Director-level insider made a modest open-market share purchase.
Henry Chung, president and director of Crescent Capital BDC, Inc., executed an open-market purchase of 4,500 common shares at $11.45 per share. Open-market buys generally reflect a deliberate decision to increase personal exposure using cash.
After the trade, Chung directly holds 20,722 shares, which includes 945 shares accumulated via dividend reinvestment in 2026. The filing shows no derivative positions, so this move purely increases common stock ownership rather than converting options or other instruments.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 4,500 | $11.45 | $52K |
Footnotes (1)
- F1. Includes 945 shares acquired through dividend reinvestment in 2026 and not previously reported pursuant to Rule 16a-11 under the Securities Act of 1934.
Key Figures
Key Terms
open-market purchase financial
dividend reinvestment financial
Rule 16a-11 regulatory
Form 4 regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Crescent Capital BDC (CCAP) president Henry Chung report in this Form 4?
Was Henry Chung’s Crescent Capital BDC (CCAP) trade an open-market transaction?
What does the dividend reinvestment footnote mean in Henry Chung’s CCAP filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.